GlassScriptPhysician profile
Rose M Ibrahim
NPI 1902576150
$2,216.94
in general payments reported to CMS, 2019-2025
11 companies · $2,217 in 2025
The $2,217 reported for 2025 was more than what 96% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $2,217.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,204 · Travel and Lodging: $1,013.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,203.98 |
| Travel and Lodging | $1,012.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tela Bio, INC. | $1,012.96 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Integra Lifesciences Corporation | $435.11 | 2025 | Integra, Integra Dermal Regeneration Template, Surgimend |
| Ethicon US, LLC | $238.58 | 2025 | Vistaseal, Ethicon |
| Davol INC. | $136.08 | 2025 | Phasix Mesh, Arista |
| Organogenesis INC. | $109.46 | 2025 | Puraply Wound Matrix |
| Abbvie INC. | $103.25 | 2025 | |
| Avita Medical Americas, LLC | $65.57 | 2025 | Cohealyx, Permeaderm, Recell |
| Mentor Worldwide LLC | $34.64 | 2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Solventum Corporation | $32.67 | 2025 | V.A.C.Ulta, V.A.C.Instill, Prevena |
| Stryker Corporation | $30.59 | 2025 | Spy-Phi System |
| Smith+Nephew, INC. | $18.03 | 2025 | Collagenase Santyl |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rose Ibrahim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.